The Portuguese Association of Bioindustry Companies (P-BIO) organizes, with the support of the Ministry of Science, Technology and Higher Education, the “P-BIO Pledge 4 COVID” initiative. The project will be presented in two sessions: tomorrow (at Teatro Thalia, in Lisbon) and May 19 (at CEiiA’s facilities, in Matosinhos).
The initiative aims to encourage the participation of Portuguese start-ups in the Bioindustries area in the global cooperation platform “Global Response to COVID-19”, launched on April 24th and which has already attracted around 7.5 billion euros to the investment in the areas of diagnosis, therapies/treatments, and vaccine development.
The first presentation session will take place tomorrow, starting at 2 pm, at Teatro Thalia, and it can also be followed online. The session will be attended by Manuel Heitor, Minister of Science, Technology and Higher Education, and André de Aragão Azevedo, Secretary of State for Digital Transition.
The next session takes place at the CEiiA facilities, in Matosinhos, on May 19, also starting at 2:00 pm. In addition to Manuel Heitor at the opening, Ana Abrunhosa, Minister for Territorial Cohesion, will be present to close the session.
The support for the participation of Portuguese start-ups in international networks aims to stimulate partnerships in each of the three pillars of the initiative:
- Diagnosis, essential until there is an effective vaccine. The Portuguese scientific and technological system already participates actively in the development and realization of tests and diagnostic systems, including the use of nanotechnologies, which makes Portugal in a position of excellence to contribute to the Global Fund for Innovative Diagnostics (FIND ).
- Therapies/treatment: the Portuguese industry is actively involved in the production of critical components for antiviral medical therapies, being prepared to increase our production capacity and contribute to the Therapeutic Accelerator at a global level (ACT Therapeutic Partnership).
- Vaccines: the national scientific community is prepared to join forces with partners worldwide in the context of CEPI and GAV, the coalition for preventive innovation against the pandemic.
The “Global Response to COVID-19” platform brings together a group of organizations committed to the development of solutions to combat COVID-19, such as the World Health Organization (WHO) or the G20 countries. Portugal joined this project through donations from the public and private sectors.